HEALTH TECHNOLOGY

KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium

KORU Medical | October 05, 2022 | Read time : 01:00 min

KORU Medical

KORU Medical Systems, Inc. a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, announced its membership in the Subcutaneous (SC) Drug Development & Delivery Consortium making it one of the first device companies to be added to the Consortium.

The Consortium creates an important forum to identify and address key challenges and opportunities across the SC field. Key industry experts can collaborate on issues at the clinical, regulatory, and commercial level and work towards advancing the SC market and creating the best outcomes for patients. I am excited for KORU Medical’s membership as one of the first device companies and look forward to advancing SC drug delivery.”

Linda Tharby, KORU Medical’s President and CEO

The Consortium was convened in 2018 as a community of well-recognized industry experts with decades of experience in the pharmaceutical drug delivery, device development, and commercialization space. The Consortium was built upon a strong desire for clear and transparent evidence-based communication of existing SC technologies and information. The Consortium’s mission is to identify current and future unmet medical needs within a dynamic SC drug delivery and development environment to transform patient care and improve patient outcomes. As a member, KORU Medical will contribute to advancing understanding of patient preference for SC therapy and the clinical trial strategy and technology for high-volume SC drugs. KORU Medical was one of the first companies to develop technology for SC biologics with volumes above 5mL, and its Freedom System is used by over 25,000 patients today to receive SC therapy. KORU Medical is established as the market leader in above 10mL and will bring this deep expertise in patient experience and subcutaneous injection technology to the Consortium.

About KORU Medical
KORU Medical develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the “Freedom System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.

Spotlight

In the Internet of Things (IoT), devices gather and share information directly with each other and the cloud, making it possible to collect, record and analyze new data streams faster and more accurately. But nowhere does the IoT offer greater promise than in the field of healthcare, where its principles are already being applied to improve access to care, increase the quality of care and most importantly reduce the cost of care.

Spotlight

In the Internet of Things (IoT), devices gather and share information directly with each other and the cloud, making it possible to collect, record and analyze new data streams faster and more accurately. But nowhere does the IoT offer greater promise than in the field of healthcare, where its principles are already being applied to improve access to care, increase the quality of care and most importantly reduce the cost of care.

Related News

HEALTHCARE ANALYTICS

Carbon Health Announces Best-in-Class Patient Outcomes from Diabetes Program

Carbon Health | December 01, 2022

In honor of National Diabetes Awareness Month in November, Carbon Health, a hybrid healthcare company that combines expert care with proprietary technology for easy everyday health, announces compelling new patient outcomes from its innovative diabetes program. To date, Carbon Health's diabetes program has helped two-thirds of its patients with uncontrolled diabetes achieve and maintain recommended glycemic targets, while patients with baseline A1c >9.0% in particular saw an impressive average A1c reduction of 4.2%. Carbon Health’s program is endocrinologist-led, integrated with primary care, and supported by a team of certified diabetes educators. It is also completely virtual, making it easily accessible to patients with no waiting or travel time involved. The Carbon Health electronic health record integrates data from continuous glucose monitors into the patient’s chart and enables seamless care coordination among all members of the care team. Patients are able to log meals and medications alongside their CGM data in the Carbon Health patient app, which is an everyday companion to their care. “Diabetes care traditionally involves fingerstick glucose monitoring and quarterly visits. We’re flipping that on its head with our measurement-based, personalized, and proactive diabetes program. We’re the only healthcare provider to integrate a combination of blood glucose data from a CGM device with food, physical activity, and medication into our electronic health record (EHR) to allow patients and their interdisciplinary care teams – including primary care providers – to have incredibly powerful insights at their fingertips. This continuous data better enables our care team to manage our patients virtually and offer proactive support when they need it the most, avoiding one-size-fits-all advice and broken handoffs.” Myoung Cha, Chief Strategy Officer at Carbon Health These new outcomes will be presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes and represent best-in-class results among a number of diabetes care solutions. A recent analysis of 204 patients in the program found that 66.8% with baseline A1c ≥7.0% are meeting the guideline-recommended 70% time in range in their latest four weeks of available CGM data. Meanwhile, 54.0% of this cohort reached 70% time in range in their first 4 weeks of participating in the program then maintained that target thereafter, indicating that glycemic control was achieved rapidly and effectively. Among patients with baseline A1c >9.0%, Carbon Health's diabetes program lowered A1c by an average of 4.2%, compared to 3.3% by a leading digital diabetes competitor. Additionally, Carbon Health has made the following enhancements to its diabetes program Meal rankings: This unique feature shows the connection between meals and blood sugar changes, helping patients to better understand on their own which meals they should favor or avoid/limit. Peer support: Diabetes care & education specialists facilitate peer support and open discussions through virtual group learning sessions. Educational content: Expanding the diabetes content library to increase patient knowledge includes offering an evidence-based comparison of popular diets and strategies for eating healthy on the road. Ongoing accountability: Carbon Health’s care team has developed bi-weekly notifications to support patients: celebrating when they reach their blood sugar goals and reaching out when they need help. The notifications also act as time-saving tools for providers, who can easily see changes and better drive care adherence. For those at higher risk of diabetes, including individuals with high blood pressure, high cholesterol and/or a family history of diabetes, Carbon Health also offers an improved metabolic health assessment in California. Due to the complete integration of CGM data with the Carbon Health app as well as meal rankings, the metabolic insights program now offers even more individualized and actionable insights so patients can see what works and make appropriate lifestyle shifts. Learn more and check eligibility for the metabolic insights program here. Diabetes and metabolic care at Carbon Health illustrate the company’s innovative care delivery model, Connective Care. Where typical primary care is anchored in a visit, Carbon Health combines technology and expert care so every patient can establish a relationship with their own integrated team, monitor and manage their health on the go, and access in-person care when and where they need it. “We’re proud of the outcomes that are driving real change for our patients. It’s truly only by leveraging this integrated primary care model that we are able to offer our patients care that is simple, flexible, and personal,” said Dr. Calvin Wu, Medical Director of the diabetes program and endocrinologist at Carbon Health. About Carbon Health Carbon Health is a modern healthcare company offering hybrid care for easier everyday health. By combining custom technology with expert care, Carbon Health enables patients to establish a direct relationship with an integrated team, monitor and manage their health on the go, and access in-person care when and where they need it. Building on the success of its nationwide urgent care network, Carbon Health treats the full spectrum of first-contact needs – from acute issues to chronic conditions, as well as ongoing physical and mental health needs. The company is also expanding into value-based care through work with employers, health plans, health systems, and other ecosystem partners.

Read More

HEALTH TECHNOLOGY

Pure Health UAE Largest Healthcare Platform Signs a Deal With Equity Group Investments to Invest Half a Billion Dollars in a U.S. Healthcare Company

Pure Health | September 05, 2022

Alpha Dhabi Holding subsidiary, Pure Health, the largest integrated healthcare platform of the United Arab Emirates announced that it has entered into a definitive purchase agreement to acquire a minority equity investment in Ardent Health Services a leading U.S. healthcare provider based in Nashville, Tennessee, for a total investment of $500 million. The investment is subject to customary closing conditions and will be finalized after receipt of all necessary U.S. regulatory approvals. Ardent is the fourth largest privately held acute care hospital operator in the U.S., with 30 hospitals and more than 200 sites of care across six states, and approximately 26,000 employees. Pure Health would achieve a minority equity investment by purchasing an interest in Ardent from Equity Group Investments a Chicago-based private investment firm and majority owner of Ardent. As part of its investment, Pure Health would receive board observer rights but would not have a seat on Ardent’s board of directors. The investment does not include plans for either the expansion of Ardent’s physical footprint or collaboration between Ardent and Pure Health in the delivery of care. Equity Group Investments hosted a signing ceremony, which included Farhan Malik, CEO of Pure Health, Sam Zell, founder and chairman of EGI, and Marty Bonick, president and chief executive officer of Ardent. “One of EGI’s strengths is partnering with like-minded individuals with the experience and passion for how we approach investment opportunities. We look forward to developing a productive relationship with Pure Health as they continue to explore the various dynamics of the U.S. healthcare system,” Sam Zell Commenting on the major investment announcement, Farhan Malik said, “This landmark investment agreement marks a quantum leap for the UAE and the global healthcare industry.” “This is an exciting opportunity for Pure Health, as we continue to build relationships with leading U.S. healthcare providers to leverage the highest standards and best clinical practices to provide an unrivalled healthcare experience for patients in the UAE,” said Malik. “Ardent has a strong track record of delivering outstanding services across the United States, and we look forward to gaining additional knowledge to support our north star of advancing the science of longevity and unlocking time for humanity.” ABOUT PURE HEALTH Pure Health is an integrated healthcare solutions platform with a diversified portfolio of over 25 hospitals and more than 100 clinics offering 200+ specialties covering services from tertiary care to primary care; health insurance that covers over 2.5 million members; group procurement organization; over 150 laboratories; diagnostics services; rehab services; long term care; medical supplies; and health technology services. With more than 50 million annual clinical encounters and over 25,000 employee strength, the company provides healthcare services across the entire continuum of care. Pure Health is committed to enhancing longevity and helping people live longer, happier, and healthier lives. The company’s centers of excellence bring together clinical knowledge, process expertise, technology, and analytics to deliver outcome-focused, world-class quality across all channels of healthcare with a mandate to future-proof the healthcare system for a world of technological singularity. ABOUT EQUITY GROUP INVESTMENTS Equity Group Investments (EGI), founded by Sam Zell more than 50 years ago, has a long track record of building public and private businesses, including the origination and growth of multi-billion-dollar companies. EGI’s flexible capital and open investment mandate enable the firm to pursue opportunistic transactions across industries and geographies, throughout the capital structure, at any point in the economic cycle. EGI’s current portfolio includes investments in transportation and logistics, health care, manufacturing, agribusiness, energy, retail, waste and infrastructure, and real estate. ABOUT ARDENT HEALTH SERVICES Ardent Health Services invests in people, technology and communities. Through its subsidiaries, Ardent owns and operates 30 hospitals and more than 200 sites of care in six states with approximately 26,000 employees, including 1,200+ employed providers. With a focus on evidence-based practices to improve quality care and patient outcomes, four Ardent hospitals were named to Leapfrog’s Top Hospitals in 2021, and eight Ardent hospitals received a Leapfrog Hospital Safety Grade of A for Spring 2022. Based in Nashville, Tennessee, Ardent is owned by current and former members of Ardent’s management team; Equity Group Investments (EGI), a Chicago-based private investment firm; and Ventas, Inc.

Read More

HEALTH TECHNOLOGY

Perimeter Medical Imaging AI Announces Commercial Placement of Perimeter S-Series OCT within National Healthcare Provider System

Perimeter Medical Imaging AI, Inc. | September 30, 2022

Perimeter Medical Imaging AI, Inc. announced the commercial placement of its flagship Perimeter S-Series OCT system at a hospital that is part of a major national healthcare system and one of the largest healthcare networks in North Texas. Perimeter is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs. “This commercial placement of our Perimeter S-Series OCT system at a hospital in a major healthcare network marks a significant milestone for us as we gain traction validating our commercial model. Perimeter S-Series OCT aims to improve patient outcomes and lower healthcare costs, and we are excited that leading surgeons and hospitals are seeing the potential of our ground-breaking technology.” Jeremy Sobotta, Perimeter’s Chief Executive Officer About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level, with 10x greater image resolution than X-ray and ultrasound, and 100x greater than MRI. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company’s ticker symbol “PINK” is a reference to the pink ribbons displayed during Breast Cancer Awareness Month.

Read More